HC Wainwright Begins Coverage on Virax Biolabs Group (NASDAQ:VRAX)
HC Wainwright started coverage on shares of Virax Biolabs Group (NASDAQ:VRAX – Get Free Report) in a research report issued to clients and investors on Monday, Marketbeat reports. The brokerage set a “buy” rating and a $3.00 price target on the stock. HC Wainwright’s price target indicates a potential upside of 173.25% from the company’s […]
HC Wainwright started coverage on shares of Virax Biolabs Group (NASDAQ:VRAX – Get Free Report) in a research report issued to clients and investors on Monday, Marketbeat reports. The brokerage set a “buy” rating and a $3.00 price target on the stock. HC Wainwright’s price target indicates a potential upside of 173.25% from the company’s […]
